Key indicators: single-crystal X-ray study; T = 150 K; mean (C-C) = 0.003 Å; R factor = 0.037; wR factor = 0.097; data-to-parameter ratio = 20.1.
Related literature
For the syntheses of similar thiazolidine compounds, see, for example: Masoudi et al. (2010) ; Darehkordia et al. (2007) and for the synthesis of a related compound, see: Mohamed et al. (2013) . For the range of biological activities of thiazolidinecontaining compounds, see: Pandeya et al. (1999) ; Shiradkar et al. (2007) ; Gududuru et al. (2004) ; Taranalli et al. (2009); Kumar et al. (2007) ; Rao et al. (2002 Rao et al. ( , 2004 ; Barreca et al. (2001) ; Solomon et al. (2007) ; Amin et al. (2008) ; Shih & Ying (2004) .
Experimental
Crystal data C 24 H 20 BrN 3 S M r = 462.40 Triclinic, P1 a = 7.9622 (5) Å b = 11.2672 (7) Å c = 11.6370 (7) Å = 96.273 (1) = 94.386 (1) = 96.302 (1) V = 1027.31 (11) Å 3 Z = 2 Mo K radiation = 2.12 mm À1 T = 150 K 0.23 Â 0.17 Â 0.14 mm
Data collection
Bruker Smart APEX CCD diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2013) T min = 0.60, T max = 0.76 18958 measured reflections 5310 independent reflections 4582 reflections with i > 2(i) R int = 0.033 Refinement R[F 2 > 2(F 2 )] = 0.037 wR(F 2 ) = 0.097 S = 1.09 5310 reflections 264 parameters H-atom parameters constrained Á max = 0.97 e Å À3 Á min = À0.52 e Å À3 Table 1 Hydrogen-bond geometry (Å , ).
Cg4 is the centroid of the C18-C23 benzene ring.
Symmetry code: (i) Àx þ 3; Ày; Àz þ 2.
Data collection: APEX2 (Bruker, 2013); cell refinement: SAINT (Bruker, 2013); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009 ).
Comment
The syntheses of a variety of thiazolidine-containing compounds have been reported (Masoudi et al., 2010; Darehkordia et al., 2007) . Such compounds have been found to possess a wide range of biological properties such as antimicrobial (Pandeya et al., 1999; Shiradkar et al., 2007) , antiproliferative (Gududuru et al., 2004) , anti-inflammatory, analgesic, anti-ulcer (Taranalli et al., 2009; Kumar et al., 2007) , anti-HIV (Rao et al., 2002; Rao et al., 2004; Barreca et al., 2001) , antimalarial (Solomon et al., 2007) , anticonvulsant (Amin et al., 2008) and antioxidant (Shih & Ying, 2004) activities.
With this in mind and to further our ongoing study on the synthesis of various derivatives of thiazolidine compounds, we herein report the crystal structure of the title compound.
In Fig. 1 , the thiazole ring (S1/N1/C1-C3) of the title compound is planar with an r.m.s. deviation of 0.002 Å. The 4bromophenyl ring (C4-C9) makes a dihedral angle of 47.96 (8)° with the thiazole ring while the phenyl group (C10-C15) attached to the ring nitrogen makes a dihedral angle of 59.52 (9)°. The dihedral angle between the 4-methylphenyl ring (C18-C23) and the thiazole ring are 16.96 (9)°.
In the crystal, the packing consists of ribbons approximately parallel to [101] and assisted by C17-H17A···Cg4 (Cg4 is the centroid of the C18-C23 ring at 3 -x, -y, 2 -z; H17A···Cg = 2.77 Å, C17-H17A···Cg = 143°) interactions (Table 1) .
Experimental
The title compound has been prepared according to our reported method (Mohamed et al., 2013) . The crude product has been crystallized from ethanol to afford translucent orange blocks suitable for X-ray diffraction (m.p.: 491 -493 K).
Refinement
H atoms were positioned geometrically and allowed to ride on their parent atoms with C-H = 0.95 (aromatic H) and 0.98 Å (methyl H), with U iso (H) = 1.2U iso (C) for aromatic H atoms and U iso (H) = 1.5U iso (C) for methyl H atoms.
Computing details
Data collection: APEX2 (Bruker, 2013); cell refinement: SAINT (Bruker, 2013); data reduction: SAINT (Bruker, 2013); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009 View of the title compound with 50% probability ellipsoids.
Figure 2
Packing of the title compound viewed down the a-axis. 
(2E)-4-(4-Bromophenyl)-2-{(2Z)-[1-(4-methylphenyl)ethylidene]hydrazinylidene}-3-phenyl-2,3-dihydro-1,3thiazole
R int = 0.033 θ max = 29.1°, θ min = 1.8°h = −10→10 k = −14→15 l = −15→15
Special details
Experimental. The diffraction data were obtained from 3 sets of 400 frames, each of width 0.5° in ω, colllected at φ = 0.00, 90.00 and 180.00° and 2 sets of 800 frames, each of width 0.45° in φ, collected at ω = -30.00 and 210.00°. The scan time was 15 sec/frame. Geometry. Bond distances, angles etc. have been calculated using the rounded fractional coordinates. All su's are estimated from the variances of the (full) variance-covariance matrix. The cell e.s.d.'s are taken into account in the estimation of distances, angles and torsion angles Refinement. Refinement on F 2 for ALL reflections except those flagged by the user for potential systematic errors. Weighted R-factors wR and all goodnesses of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The observed criterion of F 2 > σ(F 2 ) is used only for calculating -R-factor-obs etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq Br1 0.30655 (3) 0.39026 (2) 0.30405 (2) 0.0337 (1) S1 0.89651 (6) −0.07711 (4) 0.65607 (4) 0.0232 (1) 0.0238 (9) 0.0248 (9) 0.0209 (9) 0.0015 (7) −0.0013 (7) 0.0008 (7) C2 0.0186 (8) 0.0252 (9) 0.0157 (8) 0.0015 (7) 0.0008 (6) 0.0009 (6) C3 0.0212 (8) 0.0213 (8) 0.0202 (9) 0.0020 (7) 0.0017 (7) 0.0033 (7) C4 0.0173 (8) 0.0223 (9) 0.0210 (9) −0.0001 (7) −0.0010 (7) 0.0018 (7) C5 0.0213 (8) 0.0277 (9) 0.0204 (9) 0.0025 (7) 0.0011 (7) −0.0013 (7) C6 0.0253 (9) 0.0310 (10) 0.0167 (9) −0.0004 (8) −0.0020 (7) 0.0019 (7) C7 0.0215 (8) 0.0222 (9) 0.0247 (9) 0.0003 (7) −0.0051 (7) 0.0057 (7) supplementary materials sup-5
Acta Cryst. (2013). E69, o1563-o1564 C8 0.0255 (9) 0.0243 (9) 0.0255 (10) 0.0042 (7) 0.0005 (7) 0.0009 (7) C9 0.0241 (9) 0.0245 (9) 0.0185 (9) 0.0025 (7) −0.0001 (7) 0.0003 (7) C10 0.0165 (8) 0.0200 (8) 0.0230 (9) 0.0024 (6) −0.0017 (6) 0.0017 (7) C11 0.0231 (9) 0.0254 (9) 0.0220 (9) 0.0044 (7) 0.0013 (7) 0.0021 (7) 0.0224 (9) 0.0293 (10) 0.0225 (9) 0.0045 (7) 0.0004 (7) 0.0022 (7) C16 0.0187 (8) 0.0244 (9) 0.0203 (9) 0.0004 (7) 0.0018 (7) 0.0036 (7) C17 0.0327 (10) 0.0271 (10) 0.0213 (10) 0.0022 (8) −0.0002 (8) 0.0033 (7) C18 0.0184 (8) 0.0283 (9) 0.0192 (9) 0.0021 (7) 0.0030 (7) 0.0058 (7) C19 0.0257 (9) 0.0293 (10) 0.0211 (9) −0.0001 (7) 0.0000 (7) 0.0040 (7) C20 0.0258 (9) 0.0373 (11) 0.0231 (10) 0.0008 (8) −0.0007 (7) 0.0092 (8) (8) C23 0.0254 (9) 0.0298 (10) 0.0220 (9) 0.0027 (8) 0.0004 (7) 0.0035 (7) C24 0.0367 (11) 0.0373 (12) 0.0357 (12) 0.0131 (9) 0.0028 (9) 0.0114 (9) Geometric parameters (Å, º) C1-S1-C3 90.57 (9) C21-C22-C23 121.4 (2) C2-N1-C3 113.95 (15) C18-C23-C22 120.76 (18) C2-N1-C10 124.72 (15) S1-C1-H1 124.00
